SK284371B6 - Použitie oftalmologickej kompozície obsahujúcej účinné množstvo lokálneho inhibítora anhydrázy kyseliny uhličitej na prípravu liečiva - Google Patents

Použitie oftalmologickej kompozície obsahujúcej účinné množstvo lokálneho inhibítora anhydrázy kyseliny uhličitej na prípravu liečiva Download PDF

Info

Publication number
SK284371B6
SK284371B6 SK1151-98A SK115198A SK284371B6 SK 284371 B6 SK284371 B6 SK 284371B6 SK 115198 A SK115198 A SK 115198A SK 284371 B6 SK284371 B6 SK 284371B6
Authority
SK
Slovakia
Prior art keywords
alkoxy
alkyl
carbonic anhydrase
anhydrase inhibitor
optionally substituted
Prior art date
Application number
SK1151-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK115198A3 (en
Inventor
William Eric Sponsel
Alon Harris
Original Assignee
Advanced Research And Technology Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605642.9A external-priority patent/GB9605642D0/en
Application filed by Advanced Research And Technology Institute filed Critical Advanced Research And Technology Institute
Publication of SK115198A3 publication Critical patent/SK115198A3/sk
Publication of SK284371B6 publication Critical patent/SK284371B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433Thidiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541Non-condensed thiazines containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Eye Examination Apparatus (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK1151-98A 1996-02-26 1997-02-25 Použitie oftalmologickej kompozície obsahujúcej účinné množstvo lokálneho inhibítora anhydrázy kyseliny uhličitej na prípravu liečiva SK284371B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1225096P 1996-02-26 1996-02-26
GBGB9605642.9A GB9605642D0 (en) 1996-03-18 1996-03-18 Treatment of macular edema
PCT/US1997/002874 WO1997030704A2 (en) 1996-02-26 1997-02-25 Use of carbonic anhydrase inhibitors for treating macular edema

Publications (2)

Publication Number Publication Date
SK115198A3 SK115198A3 (en) 2000-01-18
SK284371B6 true SK284371B6 (sk) 2005-02-04

Family

ID=26308946

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1151-98A SK284371B6 (sk) 1996-02-26 1997-02-25 Použitie oftalmologickej kompozície obsahujúcej účinné množstvo lokálneho inhibítora anhydrázy kyseliny uhličitej na prípravu liečiva

Country Status (26)

Country Link
EP (1) EP0954305B9 (pt)
JP (1) JP4392481B2 (pt)
KR (1) KR100471586B1 (pt)
CN (1) CN1225582A (pt)
AT (1) ATE239468T1 (pt)
AU (1) AU727565B2 (pt)
BG (1) BG64525B1 (pt)
BR (1) BR9707674A (pt)
CA (1) CA2247063C (pt)
CZ (1) CZ299509B6 (pt)
DE (1) DE69721824T2 (pt)
DK (1) DK0954305T3 (pt)
EA (1) EA001681B1 (pt)
EE (1) EE03804B1 (pt)
ES (1) ES2199348T4 (pt)
HU (1) HU227161B1 (pt)
IL (1) IL125912A0 (pt)
IS (1) IS2053B (pt)
MX (1) MXPA98006961A (pt)
NO (1) NO320043B1 (pt)
NZ (1) NZ331843A (pt)
PT (1) PT954305E (pt)
SK (1) SK284371B6 (pt)
TR (1) TR199801665T2 (pt)
WO (1) WO1997030704A2 (pt)
YU (1) YU49422B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9716657D0 (en) 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9803226D0 (en) 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
CA2323749A1 (en) * 1998-03-06 1999-09-10 William E. Sponsel Composition and method for treating macular disorders
US5948801A (en) * 1998-03-09 1999-09-07 Alcon Laboratories, Inc. Treatment of retinal edema with brinzolamide
KR20010071827A (ko) * 1998-07-10 2001-07-31 앤더슨 데릭 제이. 반점성망막 퇴행에서 신혈관 신생의 예방치료
GB9902453D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902452D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902459D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902461D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902455D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB0000625D0 (en) 2000-01-13 2000-03-01 Zeneca Ltd Chemical compounds
US20030100594A1 (en) * 2001-08-10 2003-05-29 Pharmacia Corporation Carbonic anhydrase inhibitor
US20100063035A1 (en) 2006-12-15 2010-03-11 Nicox S.A. Carbonic anhydrase inhibitors derivatives
AR084194A1 (es) * 2010-12-09 2013-04-24 Fovea Pharmaceuticals Derivados de arilsulfonamida para la prevencion o el tratamiento de trastornos oftalmologicos especificos
JP2020504711A (ja) 2016-12-21 2020-02-13 バイオセリックス, インコーポレイテッド タンパク質を標的とすることにおいて使用するための、チエノピロール誘導体、その組成物、方法、および使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797413A (en) * 1986-05-14 1989-01-10 Merck & Co., Inc. Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use
GB2223166B (en) * 1988-09-29 1992-03-18 American Cyanamid Co Stable ophthalmic preparations containing methazolamide
US5153192A (en) * 1990-04-09 1992-10-06 Alcon Laboratories, Inc. Thiophene sulfonamides useful as carbonic anhydrase inhibitors

Also Published As

Publication number Publication date
WO1997030704A3 (en) 1997-09-25
PT954305E (pt) 2003-09-30
EP0954305B1 (en) 2003-05-07
EP0954305A2 (en) 1999-11-10
NO320043B1 (no) 2005-10-17
HUP9902054A3 (en) 2001-07-30
BG64525B1 (bg) 2005-06-30
CA2247063A1 (en) 1997-08-28
IS2053B (is) 2005-10-14
EP0954305B9 (en) 2010-08-04
CA2247063C (en) 2004-01-06
ES2199348T3 (es) 2004-02-16
JP4392481B2 (ja) 2010-01-06
JP2000506833A (ja) 2000-06-06
NO983906D0 (no) 1998-08-25
MXPA98006961A (es) 2004-11-19
NZ331843A (en) 2000-09-29
DK0954305T3 (da) 2003-08-25
TR199801665T2 (xx) 1998-12-21
HUP9902054A1 (hu) 2000-03-28
IS4829A (is) 1998-08-20
KR100471586B1 (ko) 2005-07-11
WO1997030704A2 (en) 1997-08-28
AU1972197A (en) 1997-09-10
EE03804B1 (et) 2002-08-15
YU49422B (sh) 2006-01-16
YU35398A (sh) 2001-12-26
CZ299509B6 (cs) 2008-08-20
CZ269998A3 (cs) 2000-01-12
AU727565B2 (en) 2000-12-14
EA199800764A1 (ru) 1999-06-24
IL125912A0 (en) 1999-04-11
HU227161B1 (en) 2010-09-28
KR19990087242A (ko) 1999-12-15
BR9707674A (pt) 2000-01-04
EA001681B1 (ru) 2001-06-25
NO983906L (no) 1998-10-19
ES2199348T4 (es) 2010-10-19
SK115198A3 (en) 2000-01-18
BG102797A (en) 1999-09-30
CN1225582A (zh) 1999-08-11
ATE239468T1 (de) 2003-05-15
DE69721824D1 (de) 2003-06-12
EE9800263A (et) 1999-08-16
DE69721824T2 (de) 2004-03-11

Similar Documents

Publication Publication Date Title
JP2022116191A (ja) 異常な新生血管形成を伴う眼疾患を処置するためにニンテダニブを使用する組成物および方法
SK284371B6 (sk) Použitie oftalmologickej kompozície obsahujúcej účinné množstvo lokálneho inhibítora anhydrázy kyseliny uhličitej na prípravu liečiva
NZ203639A (en) Topical ophthalmic compositions containing certain 5-aroyl-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-ylcarboxylic acid derivatives
CA2013167A1 (en) Isoquinoline derivatives for the treatment of glaucoma or ocular hypertension
US5049587A (en) Ophthalmic solution for intraocular pressure adjustment
RU2181045C2 (ru) Способ оздоровления глазного нерва и сетчатки глаза
KR20070040326A (ko) 백내장, 황반 변성 및 다른 안과 질환의 개선
US6046223A (en) Treatment of macular edema
JP6026699B1 (ja) 置換ガンマラクタムを含有する眼科用製剤およびその使用法
CZ285129B6 (cs) Oftalmické přípravky, obsahující kombinace inhibitoru karboanhydrasy a beta-adrenergního antagonisty
JP3066561B2 (ja) 近視予防・治療剤
CA1279015C (en) Increasing aqueous humor outflow
JP2004262812A (ja) 眼圧低下剤
JPH03106816A (ja) 緑内障治療用点眼剤
JP2002356431A (ja) ステロイドを有効成分とする網脈絡膜疾患治療剤
JPH03135952A (ja) 新規なスルフォンアミド
JP2002526409A (ja) 光障害性網膜変性疾患処置用組成物
JP2004182701A (ja) ヒドロキサム酸誘導体を有効成分とする眼組織血管新生阻害剤
CN1155243A (zh) 眼部炎症和/或伤口的预防和治疗方法

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20110225